Alibaba crackdown has implications for emerging market equities Alibaba crackdown has implications for emerging market equities Alibaba crackdown has implications for emerging market equities

Alibaba crackdown has implications for emerging market equities

Equities 4 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  China has increasingly changed regulation regarding antitrust and recently the government said that large technology companies were a threat to the Chinese consumer and competition. Last Thursday, the Chinese antitrust regulators launched an official antitrust investigation of Alibaba causing its shares to decline 8%. Today, Chinese regulators are demanding Ant (Alibaba's financial arm) to return to its 'roots' in payments 'as soon as possible' exiting its businesses in consumer loans, wealth management, and insurance. This has caused sentiment to sour across all Chinese technology stocks and with the sector being a big part of the leading index on emerging market equities this could have big implications for our positive on EM equities in 2021.

Alibaba shares are down 8% in Hong Kong today extending the decline from last Thursday when the Chinese government officially launched its antitrust investigation against Alibaba. The decline today is driven by Chinese regulators ordering Ant (Alibaba’s financial arm) to ‘as soon as possible’ to exit its businesses in consumer loans, wealth management, and insurance, and go back to its ‘roots’ in payments.

Alibaba shares on the Hong Kong Stock Exchange since inception

Source: Saxo Group

This will severely restrict growth at Ant and lower its valuation which was deemed as high as $300bn in the recently postponed IPO due to changing regulation of ‘fintech’ companies not currently under the same oversight as traditional banks in China. While last Thursday’s announcement of an official antitrust investigation of Alibaba had limited impact on Tencent, Baidu and, the market is changing its views of the wider Chinese technology sector in today’s trading.

While the Alibaba crackdown is a paradigm shift in China and will likely cause headwinds for Chinese technology stocks, we are cautious about extrapolating the events in China to the rising antitrust cases in the US and Europe against big US technology companies. Due to the differences in the political systems the playbook will not be the same and we do not think Western governments will be as aggressive. Therefore, the immediate implication is not that of US technology stocks, but emerging market equities overall as Alibaba, Tencent, Meituan, Naspers, and are 14% of the overall MSCI Emerging Markets Index (see overview of ETF holdings below). This is obviously a threat to our positive view on emerging market equities, which we have expressed in several analyses including this one from 23 November, because the Chinese technology sector is a key driver to emerging market outperformance in 2021.

iShares Core MSCI EM IMI UCITS ETF and 10 largest holdings

Source: Saxo Group
Source: Bloomberg

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.